One of two of Opthea's phase III trials for a common eye disease has failed to meet its primary endpoints, ... Read More The ...

Why didn’t analysts share the same fear that gripped investors about Sarepta stock? One reason is the known risk of acute liver injury associated with adeno-associated virus vector (AAV)-based gene ...

The Eastern Mediterranean and North Sea focused oil-and-gas company said Friday that Carlyle had failed to obtain certain regulatory approvals in Italy and Egypt. It added that it had failed to reach ...

Revenues Increased 21% and Gross Profit Increased 56% Generated Fourth Quarter Adjusted EBITDA of $1.1 Million ADT Acquisition ...

Chronic Condition Special Needs Plan enrollment grew 67.3%, to 1.1 million members in 2025, the greatest annual growth in the ...

Odessa Easterlin, 37, was fatally stabbed outside Candy Market, located at 767 Market St., on April 30, 2022. The suspect, 55 ...

Plenty of volatility awaits, but this market's potential growth is enormous thanks to cost-effective technological leaps.

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

ConnectM Technology Solutions, a Marlborough-based green energy technology firm, received a delisting notice for failure to ...

The View's audience broke out in applause as Rebecca Jarvis described Elon Musk losing his wealth if Tesla's market struggles ultimately lead to failure.